News
News
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Feb 29, 2024
B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley" or the "Company"), a diversified financial services platform, today released preliminary unaudited financial results for the three and...
-
Feb 26, 2024
B. Riley Securities, a leading middle market brokerage and investment bank, and subsidiary of B. Riley Financial (Nasdaq: RILY) ("B. Riley"), today announced that it will host a Radiopharma...
-
Feb 22, 2024
Audit Committee's Review Affirms the Company Acted Properly with Regard to the Management-Led Buyout of FRG; B. Riley Financial and its Executives Had No Involvement with, or Knowledge of, Alleged...
-
Feb 22, 2024B. Riley Financial to Report Fourth Quarter and Full Year 2023 Results on Thursday February 29, 2024
B. Riley Financial, Inc. (Nasdaq: RILY) will release results for the fourth quarter and full year ending December 31, 2023 after market close on Thursday February 29, 2024. Bryant Riley, Chairman...
-
Feb 15, 2024
Following is a statement from B. Riley Financial, Inc. (Nasdaq: RILY) in response to a short report published by “The Bear Cave” on February 15, 2024. B. Riley was not contacted about the...
-
Jan 30, 2024
B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley" or the "Company") today announced that it has called for the partial redemption of $115,492,400 aggregate principal amount of its 6.75% Senior...
-
Jan 22, 2024
B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley" or the "Firm") has issued the following statement in response to a Bloomberg News article published on January 21, 2024. Yesterday, a reporter...
-
Jan 9, 2024
B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley" or the "Company") has declared cash dividends on its 6.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ: RILYP) and its 7.375% Series...
-
Jan 4, 2024
Strong business performance positioned the Company to pre-pay DIP financing package ahead of planned emergence from Chapter 11 in January
-
Dec 21, 2023
Confirmation hearing rescheduled to January 10, 2024 Equity Rights Offering subscription deadline extended to December 28, 2023 AUSTIN, Texas--(BUSINESS WIRE)-- Core Scientific, Inc. (OTC: CORZQ)...